ClinicalTrials.gov
public full text
Public Domain
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)
The purpose of this study is to see whether a new investigational drug (Imatinib) may help improve asthma in people whose symptoms are not well controlled with high dose inhaled corticosteroid treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service#1058018
- Effectiveness of Anti-IL-5/IL5R Inhibitors#841356
- Efficacy and Safety of OMT on Asthmatics#882930
- Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma#257505
- Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations#852694
Record · ID 898126
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive